Clinical trial
A Trial to Determine Radiation Exposure to Organs and Assess the Safety of…
NCT00162045 · Lantheus Medical Imaging, Industry · Completed
Key facts
| NCT number | NCT00162045 |
|---|---|
| Title | A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects |
| Official title | A Phase I-II, Open-Label, Multicenter Trial to Determine the Dosimetry and Safety of Technetium Tc99m Sestamibi in Pediatric Subjects |
| Lead sponsor | Lantheus Medical Imaging, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Kawasaki Disease |
| Intervention type | Drug |
| Interventions | Technetium Tc99m Sestamibi |
| Enrollment | 79 |
| Start date | Jan 1, 2005 |
| Primary completion | May 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Sep 13, 2005 |
| Last update posted | Jun 2, 2011 |
| Countries | Canada, Taiwan, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: